1Richardson P, Hawkey C J, Stack WA. Proton pump inhibitors: pharmacology and rationale for use in gastrointestinal disorders [ J ]. Drugs,1998,56 (3): 307-335.
2Ishizaki T, Horai Y. Review article: cytochrome P450 and the metabolism of proton pump inhibitors-emphasis on rabeprazole [ J]. Aliment Pharmacol Ther, 1999,13[ Suppl 3] :27-36.
3Meyer UA. Metabolic interactions of the proton- pump inhibitors lanseprazole, omeprazole and pantoprazole with other drugs[ J]. Eur J Gastroenterol Hepatol, 1996,8[ Suppl 1 ]: S21-S25.
4Blum RA. Lansoprazole and omeprazole in the treatment of acid peptic disorders[J]. Am J Health Syst Pharm, 1996,53(12): 1401-1415.
5Katz PO, Anderson C, Khoury R, et al. Gastro- oesophageal reflux associated with nocturnal gastric acid breakthrough on proton pump inhibitors[ J]. Aliment Pharmacol Ther, 1998,12(12): 1231-1234.
6Peghini PL, Katz PO, Bracy NA, et al. Nocturnal recovery of gastric acid secretion with twice-daily dosing of proton pump inhibitors[J]. Am J Gastroenterol, 1998,93 (5): 763-767.
7Katz PO, Hatlebakk JG, Castell DO. Gastric acidity and acid breakthrough with twice-daily omeprazole or lansoprazole[J]. Aliment Pharmacol Ther,2000,14(6) :709-714.
8Hatlebakk JG, Katz PO, Kuo B, et al. Nocturnal gastric acidity and acid breakthrough on different regimens of omeprazole 40 mg daily[ J]. Aliment Pharmacol Ther, 1998,12(2): 1235-1240.
9Dammann HG, Burkhardt F. Pantoprazole versus omeprazole: influence on meal-stimulated gastric acid secretion[J]. Eur J Gastroenterol Hepatol, 1999,11 ( 11 ): 1277-1282.
10Earnest DL, Robinson M. Treatment advances in acid secretory disorders: the promise of rapid symptom relief with disease resolution[J]. Am J Gastroenterol, 1999,94[ Suppl 11 ]: S17-S24.
